During the recent session, Astrazeneca plc ADR (NASDAQ:AZN)’s traded shares were 1.3 million, with the beta value of the company hitting 0.40. At the last check today, the stock’s price was $67.82, reflecting an intraday loss of -3.20% or -$2.25. The 52-week high for the AZN share is $87.68, that puts it down -29.28 from that peak though still a striking 9.7% gain since the share price plummeted to a 52-week low of $61.24. The company’s market capitalization is $210.34B, and the average trade volume was 6.09 million shares over the past three months.
Astrazeneca plc ADR (AZN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.34. AZN has a Sell rating from 0 analyst(s) out of 10 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 8 recommend a Buy rating for it.
Astrazeneca plc ADR (NASDAQ:AZN) trade information
Astrazeneca plc ADR (AZN) registered a -3.20% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.20% in intraday trading to $67.82, hitting a weekly high. The stock’s 5-day price performance is -3.81%, and it has moved by 4.51% in 30 days. Based on these gigs, the overall price performance for the year is -10.47%.
The consensus price target of analysts on Wall Street is $88, which implies an increase of 22.93% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $88 and $88 respectively. As a result, AZN is trading at a discount of -29.76% off the target high and -29.76% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 34.63%. While earnings are projected to return 9.64% in 2025, the next five years will return 11.16% per annum.
AZN Dividends
Astrazeneca plc ADR is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Astrazeneca plc ADR is 1.55, with the dividend yield indicating at 2.29 percent, continuing the trend of increasing dividends in recent years.
The next largest institutional holding, with 42.6 million shares, is of PRIMECAP MANAGEMENT CO/CA/’s that is approximately 2.7411% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $3.32 billion.
Also, the Mutual Funds coming in first place with the largest holdings of Astrazeneca plc ADR (AZN) shares are VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund and WASHINGTON MUTUAL INVESTORS FUND . Data provided on Dec 31, 2024 indicates that VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund owns about 25.51 shares. This amounts to just over 0.97 percent of the company’s overall shares, with a $1.73 billion market value. The same data shows that the other fund manager holds slightly less at 20.06, or about 0.76% of the stock, which is worth about $1.36 billion.
